Vitti P, De Wolf M J, Acquaviva A M, Epstein M, Kohn L D
Proc Natl Acad Sci U S A. 1982 Mar;79(5):1525-9. doi: 10.1073/pnas.79.5.1525.
Thyrotropin increases the ADP-ribosylation activity of bovine thyroid membranes. Rapid ADP-ribosylation of membrane components is followed by increasing ADP-ribosylation of components in the supernatant of the reaction mixture. One of the major membrane proteins ADP-ribosylated in the thyrotropin-stimulated reaction has an approximate molecular weight of 40,000; this same protein is also a major ADP-ribosylated product of the A promoter of cholera toxin and appears to be related to the G regulatory subunit of the adenylate cyclase complex. The ADP-ribosylated products appearing in the supernatant solution comigrate with thyrotropin and preparations of 125I-labeled alpha subunit of thyrotropin; the alpha subunit, but not the beta subunit, of thyrotropin can be ADP-ribosylated by the membrane ADP-ribosyltransferase activity. NAD can be shown to enhance the ability of thyrotropin to stimulate the adenylate cyclase activity of bovine thyroid membrane preparations and of membrane preparations of a rat thyroid tumor whose adenylate cyclase activity is otherwise unresponsive to thyrotropin. The beta subunit of thyrotropin inhibits thyrotropin stimulation of both the ADP-ribosylation and adenylate cyclase activities of the thyroid membrane.
促甲状腺激素可增加牛甲状腺膜的ADP-核糖基化活性。膜成分的快速ADP-核糖基化之后是反应混合物上清液中成分的ADP-核糖基化增加。在促甲状腺激素刺激反应中被ADP-核糖基化的主要膜蛋白之一,其分子量约为40,000;该相同蛋白也是霍乱毒素A启动子的主要ADP-核糖基化产物,并且似乎与腺苷酸环化酶复合物的G调节亚基有关。出现在上清液中的ADP-核糖基化产物与促甲状腺激素以及促甲状腺激素125I标记的α亚基制剂一起迁移;促甲状腺激素的α亚基而非β亚基可被膜ADP-核糖基转移酶活性进行ADP-核糖基化。NAD可增强促甲状腺激素刺激牛甲状腺膜制剂以及大鼠甲状腺肿瘤膜制剂腺苷酸环化酶活性的能力,该大鼠甲状腺肿瘤的腺苷酸环化酶活性在其他情况下对促甲状腺激素无反应。促甲状腺激素的β亚基抑制甲状腺膜的ADP-核糖基化和腺苷酸环化酶活性的促甲状腺激素刺激作用。